Bleakley Financial Group »

Compass Therapeutics shares owned by Bleakley Financial Group

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by Bleakley Financial Group from 13F filings

Historical chart of Bleakley Financial Group investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by Bleakley Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by Bleakley Financial Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $21k 11k 1.84
2024-03-31 $80k 40k 1.98

More positions owned by Bleakley Financial Group

Vanguard Index Fds Large Cap Etf (VV)
Apple (AAPL)
Sprott Physical Gold & Silve Tr Unit (CEF)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Index Fds Value Etf (VTV)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
NVIDIA Corporation (NVDA)
Sprott Physical Gold Tr Unit (PHYS)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Amazon (AMZN)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Vanguard Malvern Fds Strm Infproidx (VTIP)

View all positions for Bleakley Financial Group

Top funds holding Compass Therapeutics

OrbiMed Advisors
Blackstone Group
BlackRock
BlackRock
Rock Springs Capital Management
Henderson Group
MPM Oncology Impact Management
Vanguard Group
Blue Owl Capital Holdings
Geode Capital Management
Cormorant Asset Management
State Street Corporation
Tang Capital Management
Baker Bros. Advisors
Northern Trust

View all funds holding Compass Therapeutics